A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy. - Contacts and Locations

Contacts

Contact: Pfizer CT.gov Call Center

1-800-718-1021

Locations

United States, Alabama
Pfizer Investigational Site	Active, not recruiting
Anniston, Alabama, United States, 36207
Pfizer Investigational Site	Active, not recruiting
Birmingham, Alabama, United States, 35235
United States, California
Pfizer Investigational Site	Active, not recruiting
Mission Viejo, California, United States, 92691
United States, Colorado
Pfizer Investigational Site	Recruiting
Denver, Colorado, United States, 80209
United States, Connecticut
Pfizer Investigational Site	Completed
New Britain, Connecticut, United States, 06050
Pfizer Investigational Site	Active, not recruiting
Waterbury, Connecticut, United States, 06708
United States, Florida
Pfizer Investigational Site	Active, not recruiting
Tampa, Florida, United States, 33609
Pfizer Investigational Site	Active, not recruiting
Winter Haven, Florida, United States, 33880
United States, Kentucky
Pfizer Investigational Site	Active, not recruiting
Louisville, Kentucky, United States, 40213
Pfizer Investigational Site	Active, not recruiting
Lexington, Kentucky, United States, 40503
United States, Massachusetts
Pfizer Investigational Site	Recruiting
N. Dartmouth, Massachusetts, United States, 02747
United States, Mississippi
Pfizer Investigational Site	Active, not recruiting
Tupelo, Mississippi, United States, 38801
Pfizer Investigational Site	Active, not recruiting
Jackson, Mississippi, United States, 39202
United States, Missouri
Pfizer Investigational Site	Active, not recruiting
Marionville, Missouri, United States, 65705
Pfizer Investigational Site	Active, not recruiting
Springfield, Missouri, United States, 65807
United States, New Jersey
Pfizer Investigational Site	Completed
Hamilton, New Jersey, United States, 08690
Pfizer Investigational Site	Active, not recruiting
Hamilton, New Jersey, United States, 08690
Pfizer Investigational Site	Active, not recruiting
Elizabeth, New Jersey, United States, 07207
United States, New York
Pfizer Investigational Site	Active, not recruiting
New York, New York, United States, 10024
Pfizer Investigational Site	Completed
Buffalo, New York, United States, 14209
Pfizer Investigational Site	Active, not recruiting
New York, New York, United States, 10021
United States, Rhode Island
Pfizer Investigational Site	Completed
Cranston, Rhode Island, United States, 02920
Pfizer Investigational Site	Completed
Cumberland, Rhode Island, United States, 02864
United States, South Carolina
Pfizer Investigational Site	Completed
Myrtle Beach, South Carolina, United States, 29572
United States, Tennessee
Pfizer Investigational Site	Active, not recruiting
Bartlett, Tennessee, United States, 38133
United States, Texas
Pfizer Investigational Site	Completed
Dallas, Texas, United States, 75230
Pfizer Investigational Site	Completed
Dallas, Texas, United States, 75246
Pfizer Investigational Site	Completed
Dallas, Texas, United States, 75390-8858
Pfizer Investigational Site	Active, not recruiting
Houstan, Texas, United States, 77079
Pfizer Investigational Site	Active, not recruiting
Houston, Texas, United States, 77081
Pfizer Investigational Site	Active, not recruiting
Beaumont, Texas, United States, 77701
Pfizer Investigational Site	Active, not recruiting
Beaumont, Texas, United States, 77706
United States, Wisconsin
Pfizer Investigational Site	Completed
Milwaukee, Wisconsin, United States, 53209
Czech Republic
Pfizer Investigational Site	Active, not recruiting
Ceske Budejovice, Czech Republic, 370 87
Pfizer Investigational Site	Active, not recruiting
Brno, Czech Republic, 636 00
Pfizer Investigational Site	Active, not recruiting
Ostrava, Czech Republic, 702 00
Czech Republic, 760 01
Pfizer Investigational Site	Active, not recruiting
Zlin, 760 01, Czech Republic
Finland
Pfizer Investigational Site	Active, not recruiting
Lahti, Finland, 15110
Pfizer Investigational Site	Active, not recruiting
Helsinki, Finland, 00290
Pfizer Investigational Site	Active, not recruiting
Kokkola, Finland, 67100
Pfizer Investigational Site	Active, not recruiting
Lohja, Finland, 08200
Netherlands
Pfizer Investigational Site	Active, not recruiting
Almere, Netherlands, 1311 RL
Pfizer Investigational Site	Active, not recruiting
Amsterdam, Netherlands, 1105 AZ
Pfizer Investigational Site	Active, not recruiting
Venlo, Netherlands, 5912 BL
South Africa
Pfizer Investigational Site	Recruiting
Cape Town, South Africa, 7130
South Africa, Cape Town
Pfizer Investigational Site	Recruiting
Worcester, Cape Town, South Africa, 6850
South Africa, Free State
Pfizer Investigational Site	Recruiting
Bloemfontein, Free State, South Africa, 9301
South Africa, Gauteng
Pfizer Investigational Site	Recruiting
Ennerdale, Gauteng, South Africa, 1820
Pfizer Investigational Site	Recruiting
Tshwane, Gauteng, South Africa, 0204
South Africa, Kwa- Zulu Natal
Pfizer Investigational Site	Recruiting
Stanger, Kwa- Zulu Natal, South Africa, 4450
South Africa, KwaZulu Natal
Pfizer Investigational Site	Recruiting
Durban, KwaZulu Natal, South Africa, 4000
Spain
Pfizer Investigational Site	Active, not recruiting
BARCELONA, Spain, 08035
Pfizer Investigational Site	Active, not recruiting
MADRID, Spain, 28040
Pfizer Investigational Site	Active, not recruiting
PONTEVEDRA, Spain, 36071
Pfizer Investigational Site	Active, not recruiting
VALENCIA, Spain, 46014
Spain, BARCELONA
Pfizer Investigational Site	Active, not recruiting
L'HOSPITALET DE LLOBREGAT, BARCELONA, Spain, 08907
Spain, LA CORUÑA
Pfizer Investigational Site	Active, not recruiting
SANTIAGO DE COMPOSTELA, LA CORUÑA, Spain, 15706

Sponsors and Collaborators

Pfizer

Investigators

Study Director:

Pfizer CT.gov Call Center

Pfizer